| abstract |
The present invention provides compounds of Formula (I): n n n n n n n n n n and pharmaceutically acceptable salts, solvates, esters, and tautomers thereof, wherein:n Q is selected from the group consisting of: n n n n n n n n n n n n n andn L is selected from the group consisting of: n n n n n n n n n n n n n pharmaceutically compositions comprising one or more compounds of formula (I), and methods of using the compounds of formula (I). |